Delivery Order SPE2DB20D3103-SPE2DB22FM4X9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,633.80 firm fixed-price delivery order is for the supply of Doxil 50 mg/25 ml vials, with a completion date of December 30, 2021. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the U.S. Department of...
- This federal contract award is for the delivery of DOXIL 50 MG/25 ML VIAL 25ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., doing business as Amerisourcebergen. The contract has a firm fixed price of $20,383.96 and a completion date of January 11, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,399.76 firm fixed-price delivery order covers the supply of the specialty drug DOXIL 20 MG/10 ML VIAL 10ML, with a period of performance through December 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a $1,691.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564010703 ! DOXIL 20 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as Amerisourcebergen's primary contract vehicle to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Doxil 50 mg/25 ml vials. The order has a potential value of $3,051.42 and a completion date of December 28, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and distribution...
- This federal contract award is a delivery order for DOXIL 20 MG/10 ML VIAL 10ML, a specialty pharmaceutical product, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,314.72 and an ultimate completion date of November 29, 2022. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp's parent...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,500.00 for the supply of Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 31, 2024. This Delivery Order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026....
- This federal contract award is for the delivery of Doxorubicin Liposome 50mg/25ml pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,485.80 Firm Fixed Price Delivery Order has a completion date of May 3, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,046.64 Delivery Order (DO) is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen). This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $70,299.27 awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM4X9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4556117258 - Doxil 50 mg/25 ml vials. The firm-fixed-price delivery order, valued at $8,435.30, has a completion date of February 2, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization and registered vendor in the System for Award Management (SAM.gov). AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal agencies. This contract award is likely part of this larger IDC, enabling the efficient procurement of essential pharmaceutical commodities to support military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 2/1/22 |